Fabris, B <br/><br/>
Control of glomerular hyperfiltration and renal hypertrophy by an angiotensin converting enzyme inhibitor prevents the progression of renal damage in hypertensive diabetic rats.  [electronic resource] 

 -  Journal of hypertension  Dec 1999 
 - 1925-31 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>0263-6352 
<br/><br/><label>Standard No.: </label>10.1097/00004872-199917121-00023  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Angiotensin-Converting Enzyme Inhibitors--pharmacology<br/>Animals<br/>Antihypertensive Agents--pharmacology<br/>Blood Pressure--drug effects<br/>Diabetic Angiopathies--drug therapy<br/>Diabetic Nephropathies--physiopathology<br/>Disease Progression<br/>Diuretics<br/>Drug Therapy, Combination<br/>Enalapril--analogs & derivatives<br/>Glomerular Filtration Rate<br/>Hydralazine--pharmacology<br/>Hydrochlorothiazide--pharmacology<br/>Hypertension--drug therapy<br/>Hypertrophy<br/>Kidney--pathology<br/>Male<br/>Proteinuria--urine<br/>Rats<br/>Rats, Inbred SHR<br/>Reserpine--pharmacology<br/>Sodium Chloride Symporter Inhibitors--pharmacology